These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37500384)

  • 1. Corrigendum to "Inhibition of MRP4 alleviates sepsis-induced acute lung injury in rats" [Int. Immunopharmacol. 72 (2019) 211-217].
    Xia W; Zhang H; Pan Z; Li G; Zhou Q; Hu D; Liu Y
    Int Immunopharmacol; 2023 Sep; 122():110699. PubMed ID: 37500384
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of MRP4 alleviates sepsis-induced acute lung injury in rats.
    Xia W; Zhang H; Pan Z; Li G; Zhou Q; Hu D; Liu Y
    Int Immunopharmacol; 2019 Jul; 72():211-217. PubMed ID: 30995593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "(E)-2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol alleviates inflammatory responses in LPS-induced mice liver sepsis through inhibition of STAT3 phosphorylation" [Int. Immunopharmacol. 125(Part B) (2023) 111124].
    Kim B; Yu JE; Yeo IJ; Son DJ; Lee HP; Roh YS; Lim KH; Yun J; Park H; Han SB; Hong JT
    Int Immunopharmacol; 2024 Aug; 137():112543. PubMed ID: 38926074
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "MEGF6 prevents sepsis-induced acute lung injury in mice" [Int. Immunopharmacol. 123 (2023) 110727].
    Liang H; Liu G; Zeng W; Fan Q; Nie Z; Hu H; Zhang R; Xie S
    Int Immunopharmacol; 2024 May; 133():111787. PubMed ID: 38641473
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Exosomal miR-127-5p from BMSCs alleviated sepsis-related acute lung injury by inhibiting neutrophil extracellular trap formation" [Int. Immunopharmacol. 123 (2023) 110759].
    Zheng XL; Gu WJ; Zhang F; Zhao FZ; Li LZ; Huang HY; Li LJ; Yi YH; Yin HY; Xu J
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111076. PubMed ID: 37866976
    [No Abstract]   [Full Text] [Related]  

  • 6. MiR-490 alleviates sepsis-induced acute lung injury by targeting MRP4 in new-born mice.
    Lin J; Lin Z; Lin L
    Acta Biochim Pol; 2021 Mar; 68(2):151-158. PubMed ID: 33751878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum to "Liproxstatin-1 alleviates LPS/IL-13-induced bronchial epithelial cell injury and neutrophilic asthma in mice by inhibiting ferroptosis" [Int. Immunopharmacol. 109 (2022) 108770].
    Bao C; Liu C; Liu Q; Hua L; Hu J; Li Z; Xu S
    Int Immunopharmacol; 2023 Feb; 115():109482. PubMed ID: 36610897
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "Molsidomine alleviates acetic acid-induced colitis in rats by reducing oxidative stress, inflammation and apoptosis" [Int. Immunopharmacol. 99 (2021) 108005].
    Mohamed NI; Suddek GM; El-Kashef DH
    Int Immunopharmacol; 2022 Apr; 105():108575. PubMed ID: 35115257
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "Neutrophil elastase in dexmedetomidine alleviating sepsis-related renal injury in rats" [Int. Immunopharmacol. 122 (2023) 110441].
    Chen L; Li M; Lin Y; Li Y; Liang M; Zeng K
    Int Immunopharmacol; 2024 Feb; 128():111577. PubMed ID: 38281885
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Pmepa1 knockdown alleviates SpA-induced pyroptosis and osteogenic differentiation inhibition of hBMSCs via p38MAPK/NLRP3 axis" [Int. Immunopharmacol. 124(Part A) (2023) 110843].
    Li M; Shi X; Wu Y; Qi B; Zhang C; Wang B; Zhang B; Xu Y
    Int Immunopharmacol; 2023 Nov; 124(Pt A):111013. PubMed ID: 37806790
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Emodin attenuates acute lung injury in cecal-ligation and puncture rats" [Int. Immunopharmacol. 85 (2020) 106626].
    Guo R; Li Y; Han M; Liu J; Sun Y
    Int Immunopharmacol; 2023 Sep; 122():110700. PubMed ID: 37507324
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "Icosapent ethyl alleviates acetic acid-induced ulcerative colitis via modulation of SIRT1 signaling pathway in rats" [Int. Immunopharmacol. 115 (2023) 109621].
    Ahmed Abdelsameea A; Ebrahim Alsemeh A; Alabassery N; Samy W; Fawzy A; Abbas NAT
    Int Immunopharmacol; 2024 Oct; 140():112647. PubMed ID: 39107183
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "Gypenoside XLIX attenuates sepsis-induced splenic injury through inhibiting inflammation and oxidative stress" [Int. Immunopharmacol. 127 (2024) 111420].
    Xu B; Yang R; Qiang J; Xu X; Zhou M; Ji X; Lu Y; Dong Z
    Int Immunopharmacol; 2024 Apr; 131():111694. PubMed ID: 38368241
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "Sophoricoside attenuates lipopolysaccharide-induced acute lung injury by activating the AMPK/Nrf2 signaling axis" [Int. Immunopharmacol. 90 (2021) 107187].
    Wu YX; Zeng S; Wan BB; Wang YY; Sun HX; Liu G; Gao ZQ; Chen D; Chen YQ; Lu MD; Pang QF
    Int Immunopharmacol; 2023 Nov; 124(Pt A):111008. PubMed ID: 37806791
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Atorvastatin calcium alleviates 5-fluorouracil-induced intestinal damage by inhibiting cellular senescence and significantly enhances its antitumor efficacy" [Int. Immunopharmacol. 121 (2023) 110465].
    Xia J; He S; Dai Q; Jia H; Ge Y; Zhou M; Wang XB
    Int Immunopharmacol; 2023 Aug; 121():110620. PubMed ID: 37455170
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Curcumin attenuates sepsis-induced acute organ dysfunction by preventing inflammation and enhancing the suppressive function of Tregs" [Int. Immunopharmacol. 61 (2018) 1-7].
    Chen L; Lu Y; Zhao L; Hu L; Qiu Q; Zhang Z; Li M; Hong G; Wu B; Zhao G; Lu Z
    Int Immunopharmacol; 2024 Aug; 137():112471. PubMed ID: 38879417
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "Oleamide suppresses inflammatory responses in LPS-induced RAW264.7 murine macrophages and alleviates paw edema in a carrageenan-induced inflammatory rat model" [Int. Immunopharmacol. 56 (2018) 179-185].
    Moon SM; Lee SA; Hong JH; Kim JS; Kim DK; Kim CS
    Int Immunopharmacol; 2018 Jul; 60():246. PubMed ID: 29789261
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Intravenous immunoglobulin alleviates Japanese encephalitis virus-induced peripheral neuropathy by inhibiting the ASM/ceramide pathway" [Int. Immunopharmacol. 133 (2024) 112083].
    Zhang N; Wang G; Yang L; Zhang J; Yuan Y; Ma L; Wang H; Wang Z
    Int Immunopharmacol; 2024 Jun; 134():112270. PubMed ID: 38762402
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "PAD4 selective inhibitor TDFA protects lipopolysaccharide-induced acute lung injury by modulating nuclear p65 localization in epithelial cells" [Int. Immunopharmacol. 88 (2020) 106923].
    Zhao X; Gu C; Wang Y
    Int Immunopharmacol; 2023 Dec; 125(Pt B):111185. PubMed ID: 37957096
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "GTS-21 attenuates ACE/ACE2 ratio and glycocalyx shedding in lipopolysaccharide-induced acute lung injury by targeting macrophage polarization derived ADAM-17" [Int. Immunopharmacol. 129 (2024) 111603].
    Zhu W; Wang F; Hu C; Zhao Q; Zhang D; Wang X; Hu B; Li J
    Int Immunopharmacol; 2024 May; 132():111914. PubMed ID: 38582738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.